WO2020048796A1 - Gaine d'aiguille - Google Patents

Gaine d'aiguille Download PDF

Info

Publication number
WO2020048796A1
WO2020048796A1 PCT/EP2019/072578 EP2019072578W WO2020048796A1 WO 2020048796 A1 WO2020048796 A1 WO 2020048796A1 EP 2019072578 W EP2019072578 W EP 2019072578W WO 2020048796 A1 WO2020048796 A1 WO 2020048796A1
Authority
WO
WIPO (PCT)
Prior art keywords
opening
needle
protrusions
needle guard
delivery device
Prior art date
Application number
PCT/EP2019/072578
Other languages
English (en)
Inventor
Anders Holmqvist
Original Assignee
Shl Medical Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shl Medical Ag filed Critical Shl Medical Ag
Priority to US17/056,702 priority Critical patent/US20210205544A1/en
Priority to EP19755936.2A priority patent/EP3846881A1/fr
Publication of WO2020048796A1 publication Critical patent/WO2020048796A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/31—Details
    • A61M5/32—Needles; Details of needles pertaining to their connection with syringe or hub; Accessories for bringing the needle into, or holding the needle on, the body; Devices for protection of needles
    • A61M5/3202—Devices for protection of the needle before use, e.g. caps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/31—Details
    • A61M5/32—Needles; Details of needles pertaining to their connection with syringe or hub; Accessories for bringing the needle into, or holding the needle on, the body; Devices for protection of needles
    • A61M5/3205—Apparatus for removing or disposing of used needles or syringes, e.g. containers; Means for protection against accidental injuries from used needles
    • A61M5/321—Means for protection against accidental injuries by used needles
    • A61M5/3243—Means for protection against accidental injuries by used needles being axially-extensible, e.g. protective sleeves coaxially slidable on the syringe barrel
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/31—Details
    • A61M5/32—Needles; Details of needles pertaining to their connection with syringe or hub; Accessories for bringing the needle into, or holding the needle on, the body; Devices for protection of needles
    • A61M5/3205—Apparatus for removing or disposing of used needles or syringes, e.g. containers; Means for protection against accidental injuries from used needles
    • A61M5/321—Means for protection against accidental injuries by used needles
    • A61M5/3243—Means for protection against accidental injuries by used needles being axially-extensible, e.g. protective sleeves coaxially slidable on the syringe barrel
    • A61M5/326—Fully automatic sleeve extension, i.e. in which triggering of the sleeve does not require a deliberate action by the user
    • A61M2005/3267—Biased sleeves where the needle is uncovered by insertion of the needle into a patient's body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/31—Details
    • A61M5/32—Needles; Details of needles pertaining to their connection with syringe or hub; Accessories for bringing the needle into, or holding the needle on, the body; Devices for protection of needles
    • A61M5/3205—Apparatus for removing or disposing of used needles or syringes, e.g. containers; Means for protection against accidental injuries from used needles
    • A61M5/321—Means for protection against accidental injuries by used needles
    • A61M5/3243—Means for protection against accidental injuries by used needles being axially-extensible, e.g. protective sleeves coaxially slidable on the syringe barrel
    • A61M5/326—Fully automatic sleeve extension, i.e. in which triggering of the sleeve does not require a deliberate action by the user

Definitions

  • the present disclosure relates to a needle guard for a medicament delivery device, and more particularly to a safety device for a needle guard having a wide opening.
  • Medicament delivery devices such as auto-injectors, safety syringes, and similar devices, often comprise a needle guard to prevent damage and contamination to the needle before use, and also to protect a user, or a person handling the device, from accidental needle sticks both before and after use.
  • the needle guard is normally tubular, in the shape of a hollow sleeve. A proximal end has an opening, through which the needle will protrude when a needle penetration is performed.
  • a needle shield remover is commonly connected to the cap and is designed to protrude into the opening of the needle guard and engage with a needle shield in which the needle is hermetically embedded.
  • a needle shield is normally either a Flexible Needle Shield (FNS) or a Rigid Needle Shield (RNS).
  • FNS Flexible Needle Shield
  • RMS Rigid Needle Shield
  • the former comprises a soft rubber sheath, whereas the latter also comprises a rigid outer shell which encloses the rubber sheath within.
  • Needle shields are usually standard components which come in a limited number of configurations and dimensions. It is normally a straightforward task to design a delivery device with regard to the needle shield. However, when the needle shield remover has to be re-designed it may have far-reaching consequences for the design of other components and mechanisms of the delivery device. It is especially disadvantageous if adaptation of the needle shield remover is required in a late stage of the development of the device, or even during production or after launch of a product. One adaptation that might be necessary would be to increase a radius of the needle shield remover, for instance in order for the remover to be able to engage a wider needle shield. Consequently, the opening of the needle guard would also have to be made wider. But a wider opening means reduced protection of the needle inside, after the needle shield is removed, since it is easier to access the needle through a wide opening.
  • distal refers to the direction pointing away from the dose delivery site.
  • distal part/end refers to the part/end of the delivery device, or the parts/ends of the members thereof, which under use of the medicament delivery device is/are located furthest away from the dose delivery site.
  • proximal refers to the direction pointing to the dose delivery site.
  • proximal part/end refers to the part/end of the delivery device, or the parts/ends of the members thereof, which under use of the medicament delivery device is/are located closest to the dose delivery site.
  • the term“longitudinal”, with or without“axis”, refers to a direction or an axis through the device or components thereof in the direction of the longest extension of the device or the component.
  • the term“lateral”, with or without“axis”, refers to a direction or an axis through the device or components thereof in the direction of the broadest extension of the device or the component.“Lateral” may also refer to a position to the side of a
  • the terms“radial” or“transversal”, with or without“axis”, refers to a direction or an axis through the device or components thereof in a direction generally perpendicular to the longitudinal direction, e.g.“radially outward” would refer to a direction pointing away from the longitudinal axis.
  • a general object of the present disclosure is to provide a needle guard for a medicament delivery device, which needle guard comprises a body having a proximal end and a distal end, the proximal end having a generally circular opening of a predetermined diameter d, proximally directed protrusions arranged on a rim of the opening, and wherein the proximally directed protrusions extend a predetermined length p from the rim of the opening such that a maximum intrusion depth i, of an object of a predetermined diameter D, into the opening, is reduced by p.
  • the protrusions thus enable a wider opening with maintained safety and without changing the stroke length of the needle guard because they will prevent an object from coming in contact with the needle, but will sink into the skin of a user to allow the needle penetration and injection to be performed at the correct injection depth.
  • the object is a generally spherical object and D is greater than d.
  • a spherical object of a certain diameter D is used to test the safety requirements of a needle guard. Therefore, the protrusions will fulfil the regulations if they reduce the intrusion depth of such a spherical object.
  • the protrusions are arranged on the rim at the edge of the opening and configured such that a distance between proximal ends of protrusions on opposing sides of the opening generally equals d.
  • the position of the protrusions at the edge of the opening results in the needle guard, and its opening of a certain diameter d, being“extended” proximally without elongating the needle guard itself or its stroke length. This serves to keep the object away from the needle, i.e. to reduce the intrusion depth of the object.
  • the protrusions are radially flexible and inclined radially inwards in a relaxed state such that a distance d’ between proximal ends of protrusions on opposing sides of the opening is less than d.
  • the protrusions may be slightly flexible so that they so that they collapse radially inwards when a cap and its needle shield remover is removed from the medicament delivery device. In this manner, the intrusion depth of the object may be reduced even further since the accessible opening is made smaller when the protrusions extend radially inwards.
  • Fig. 1 a perspective view of a prior art medicament delivery device
  • Fig. 2 a perspective, cross-sectional view of a prior art medicament delivery device
  • Fig.3 a perspective, cross-sectional view of a medicament delivery device having a wider opening
  • Fig. 4 a perspective, cross-sectional view of a medicament delivery device according to an embodiment of the present disclosure
  • FIG. 5 cross-sectional view of a medicament delivery device having a wide opening
  • FIG. 6 cross-sectional view of a medicament delivery device according to an embodiment of the present disclosure
  • FIG. 7 cross-sectional view of a medicament delivery device according to an alternative embodiment of the present disclosure
  • Fig. 1 shows a perspective view of a state of the art medicament delivery device 100.
  • the medicament delivery device 100 has an axially elongated casing 20 which houses a medicament container 30 and a drive mechanism (not shown) arranged to drive a plunger rod 40 and a stopper 50 to pressurise a liquid medicament in the medicament container 30.
  • the pressurised medicament is intended to be expelled through an injection needle 60 (Figs 2-4), which is applied to penetrate the skin of a user at a specific dose delivery site.
  • the needle 60 is attached (or attachable) to a proximal end of the medicament container 30 and is protected by a needle guard 10, which is axially movable with respect to the casing 20 and with respect to the needle 60.
  • the user To perform the skin penetration and injection, the user holds the medicament delivery device 100 generally perpendicularly with respect to the skin, with the needle guard 10 touching the skin. The user pushes the medicament delivery device 100 proximally, causing the needle guard 10 to move distally in relation to the casing 20 and the needle 60. The relative movement exposes the needle to penetrate the skin and also activates the drive mechanism to pressurise and expel the medicament of the container 30.
  • a needle guard spring 70 (Figs 2-4) moves the needle guard 10 proximally, relative to the casing 20 and to the needle 60, into a position where the needle guard 10 is movably locked in order to protect the a person handling the used medicament delivery device 100 from accidental needle sticks.
  • the needle guard 10 Before use of the medicament delivery device 100, the needle guard 10, and consequently the needle 60, are protected by a removable cap (not shown) which covers the proximal end of the medicament delivery device 100. When the cap is in place it prevents the needle guard 10 from moving relative to the casing 20 and relative to the needle 60. Thus there is no risk of premature activation of the device or accidental needle sticks. The cap is removed by the user before injection.
  • FIG. 1 Also shown in Fig. 1 is an object 90 of a predetermined object diameter D, which is used to test regulatory requirements of needle-protective features of a medicament delivery device 100.
  • the object 90 is configured to mimic a fingertip and determines whether the needle guard 10 sufficiently shields the needle 60 of the medicament delivery device 100 in order to prevent accidental needle sticks.
  • the needle guard 10 may have a tubular shape and has a proximal end and a distal end, the proximal end having a generally circular opening 14 of a predetermined opening diameter d, through which the needle 60 may be exposed.
  • the distal end extends into the casing 20 of the medicament delivery device 100, where it is configured to interact with the drive mechanism upon movement of the needle guard 10.
  • the opening 14 is bordered by a rim 12, which rim 12 may be a generally proximally-facing annular ledge.
  • the object diameter D is greater than the opening diameter d such that the object is prevented from completely passing through the opening 14. However, a part of the object 90 may intrude into the opening 14, up to a certain intrusion depth i, measured from the proximal end of the needle guard 10.
  • the object 90 must not intrude more than a certain distance into the opening 14. In other words, the object 90 has to be stopped at a certain minimum distance from a sharp tip of the needle 60. For instance, when the object is placed on the opening 14, a distal end of the object must be at least 3,4 mm from the tip of the needle 60, i.e. a proximal end of the needle 60. Otherwise the medicament delivery device 100 will not pass the regulatory requirements.
  • Fig. 2 shows a cross-sectional view of a proximal end of the prior art medicament delivery device 100 of Fig. 1.
  • the object 90 is positioned at the opening 14, in abutment with the needle guard 10, such that the intrusion depth i may be measured.
  • some therapeutic treatments require a different size of the medicament container 30, such as a greater diameter of the container, and or a larger needle shield as discussed in the Background section.
  • the needle guard 10 would then also have to be adapted.
  • One such adaptation may be the diameter d of the opening 14, which may have to be made larger. If the opening 14 is larger, accidental needle sticks will be more likely since the tip of the needle 60 is more easily accessible through the opening 14. The larger opening 14 will also result in that the regulatory test, using the object 90, will fail.
  • the intrusion depth i is increased if the opening 14 is simply enlarged.
  • the distance between the object 90 and the tip of the needle 60 will therefore be too short to pass the test.
  • proximally directed protrusions 16 are arranged to extend a
  • Fig. 4 shows a reduced intrusion depth, as compared to the needle guard of Fig. 3, which lacks the protrusions 16.
  • Fig. 5 is a conceptualised cross-sectional view of the device of Fig. 3.
  • the opening 14 is enlarged to adapt to a larger medicament container.
  • the intrusion depth i of the object 90 is consequently determined to be too large.
  • Fig. 6 is a conceptualised cross-sectional view of the device of Fig. 4, wherein the protrusions 16 have been arranged at the rim 12 of the opening 14.
  • the protrusions extend proximally a distance p. Therefore, the intrusion depth i of the object 90 is reduced by p, allowing the needle guard to pass the test.
  • the protrusions 16 may be preferable to arrange the protrusions 16 on the rim 12, i.e. at the edge of the opening 14, in order to provide a maximum depth reduction with regard to the extension p.
  • the protrusions 16 should preferably further be configured such that a distance between proximal ends of protrusions on opposing sides of the opening generally equals the opening diameter d. In other words, it may be preferable to configure the protrusions 16 such that they do not extend radially inside the opening 14.
  • the protrusions are configured to be radially flexible and inclined radially inwards in a relaxed state such that a distance d’ between proximal ends of protrusions on opposing sides of the opening is less than the opening diameter d.
  • the protrusions 16 will be kept in a tensioned state, axially parallel around the opening 14, when the cap (not shown) covers the proximal end of the medicament delivery device 100.
  • the protrusions 16 are allowed to collapse radially inwards into the relaxed state. In this state the protrusions 16 extend radially inside the opening 14, such that the smaller diameter d’ between the proximal ends of the protrusions affects how far the object 90 may intrude into the opening 14. Thereby the intrusion depth is reduced further.
  • a suitable length p of the protrusions 16 may range between 0,5 mm - 3 mm. More preferably the length p is 1 mm - 2 mm.
  • the length of the protrusions 16 should reduce the intrusion depth i of the object 90, but should not extend so far that the stroke length of the activation movement needs to be adjusted.

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Environmental & Geological Engineering (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)

Abstract

L'invention concerne une gaine d'aiguille (10) pour un dispositif d'administration de médicament (100), laquelle gaine d'aiguille (10) comprend un corps ayant une extrémité proximale et une extrémité distale, l'extrémité proximale ayant une ouverture généralement circulaire (14) d'un diamètre prédéfini (d) ; des saillies dirigées de façon proximale (16) agencées sur un rebord (12) de l'ouverture (14) et les saillies dirigées de manière proximale (16) s'étendant sur une longueur prédéfinie (p) à partir du rebord (12) de l'ouverture (14), de telle sorte qu'une profondeur d'intrusion maximale (i), d'un objet (90) d'un diamètre prédéfini (D), dans l'ouverture (14), soit réduite de (p).
PCT/EP2019/072578 2018-09-05 2019-08-23 Gaine d'aiguille WO2020048796A1 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
US17/056,702 US20210205544A1 (en) 2018-09-05 2019-08-23 Needle guard
EP19755936.2A EP3846881A1 (fr) 2018-09-05 2019-08-23 Gaine d'aiguille

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP18192786.4 2018-09-05
EP18192786 2018-09-05

Publications (1)

Publication Number Publication Date
WO2020048796A1 true WO2020048796A1 (fr) 2020-03-12

Family

ID=63517793

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2019/072578 WO2020048796A1 (fr) 2018-09-05 2019-08-23 Gaine d'aiguille

Country Status (3)

Country Link
US (1) US20210205544A1 (fr)
EP (1) EP3846881A1 (fr)
WO (1) WO2020048796A1 (fr)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005025636A2 (fr) * 2003-09-17 2005-03-24 Dali Medical Devices Ltd. Dispositif d'injection automatique
WO2016051395A1 (fr) * 2014-10-03 2016-04-07 Dali Medical Devices Ltd. Appareil d'aiguille automatique
EP3137136A1 (fr) * 2014-04-29 2017-03-08 Carebay Europe Ltd Dispositif de réglage de profondeur d'introduction d'aiguille
WO2017102175A1 (fr) * 2015-12-14 2017-06-22 Carebay Europe Ltd Dispositif d'administration de médicament

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5634906A (en) * 1995-12-27 1997-06-03 Habley Medical Technology Corporation Needle hiding shield for a dose metering syringe
FR2922112B1 (fr) * 2007-10-11 2009-12-04 Rexam Pharma La Verpilliere Dispositif de securite pour une seringue d'injection de liquide et ensemble a seringue comprenant ce dispositif
GB2471473A (en) * 2009-06-30 2011-01-05 Owen Mumford Ltd Syringe sheath remover
EP4186545A1 (fr) * 2012-04-06 2023-05-31 Antares Pharma, Inc. Administration par injection par jet assistée par aiguille de compositions de testostérone
KR20160085829A (ko) * 2013-11-14 2016-07-18 아레스 트레이딩 에스.아. 통증-감소 부재를 갖는 의약 주입 장치

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005025636A2 (fr) * 2003-09-17 2005-03-24 Dali Medical Devices Ltd. Dispositif d'injection automatique
EP3137136A1 (fr) * 2014-04-29 2017-03-08 Carebay Europe Ltd Dispositif de réglage de profondeur d'introduction d'aiguille
WO2016051395A1 (fr) * 2014-10-03 2016-04-07 Dali Medical Devices Ltd. Appareil d'aiguille automatique
WO2017102175A1 (fr) * 2015-12-14 2017-06-22 Carebay Europe Ltd Dispositif d'administration de médicament

Also Published As

Publication number Publication date
EP3846881A1 (fr) 2021-07-14
US20210205544A1 (en) 2021-07-08

Similar Documents

Publication Publication Date Title
US10478568B2 (en) Low radial profile needle safety device
US10751482B2 (en) Pen needle tip
RU2766673C2 (ru) Захватное приспособление для ручного инъекционного устройства
EP2812046B1 (fr) Appareil injecteur à piston fixe et procédé d'utilisation
JP7319963B2 (ja) 針安全システム
FI94215C (fi) Implantaattien injektointiin tarkoitettu laite
EP1392379B1 (fr) Systeme de protection de surete pour seringues preremplies
CN103079611B (zh) 用于安全装置的针头护罩、安全装置和注射装置
TWI626969B (zh) 藥物輸送裝置
US10537688B2 (en) Safety device for prefilled syringes
US9700681B2 (en) Pen needle with quick release and/or removal system
JP2010540056A (ja) 外部ソケットに収容された自動注射器
US10661027B2 (en) Syringe comprising a bonded needle
EP3285830B1 (fr) Dispositif d'administration de médicaments
CA2984417A1 (fr) Dispositif de securite pour seringue
US8986258B2 (en) Device for receiving a hypodermic syringe and hypodermic syringe for this device
US20210205544A1 (en) Needle guard
KR102359220B1 (ko) 안전 장치 및 약물 전달 장치
CN214129793U (zh) 用于药物输送装置的针头护罩
WO2018206488A1 (fr) Dispositif d'injection incorporant un agencement de sécurité d'aiguille

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 19755936

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

ENP Entry into the national phase

Ref document number: 2019755936

Country of ref document: EP

Effective date: 20210406